All articles by Philippa Matthews
-
ReviewSuperior: The Return of Race Science
Angela Saini’s latest book is a powerful deconstruction of the research around race
-
ReviewInvisible Women: Exposing Data Bias in a World Designed for Men
Philippa Matthews reviews Caroline Criado Perez’s new book
-
ReviewI’m a Joke and So Are You: A Comedian’s Take on What Makes Us Human
Robin Ince unravels the quirks of the human mind through conversations with psychologists, neuroscientists and fellow comedians
-
ReviewForgotten women: the scientists
Philippa Matthews reviews a book looking to uncover the lost histories of women whose achievements have been left out of the textbooks
-
ReviewYou must be very intelligent: the PhD delusion
Philippa Matthews reviews a semi-autobiographical account of a PhD student in the UK
-
ReviewSoonish: Emerging technologies that will improve and/or ruin everything
A look at what could happen in the near-ish future
-
ReviewThe weathermen: their story
A book that explores humanity’s fascination with the weather, and our attempts to predict the seemingly unpredictable
-
-
ResearchAFM no longer falls flat
Functionalised AFM tip helps researchers see crude oil in a new dimension
-
-
-
ResearchMicrorobot gets to grips with bubbles
Tiny magnetic cube exploits surface tension to carry sub-millimetre objects
-
ResearchSecrets shown in a good light
UV light reads and writes invisible messages on modified paper
-
-
Business
BASF to cut 350 jobs in plant science research
Company will also close field trial sites in Hawaii, India and Puerto Rico
-
BusinessMylan to buy Meda in further generics consolidation
£6.9bn deal will give combined company ‘critical mass’ in US market
-
Business
BP to cut 7000 jobs
UK oil company reduces its workforce to cut costs in response to low oil price and charges from Deepwater Horizon incident
-
ResearchGetting the measure of transition states
Previously impossible to monitor properties of transition states found hidden in vibration spectra
-
Business
Heptares takes on new partners for drug discovery
Firm set to receive over $1bn from research partnerships